A Randomised Clinical Trial Of Cognitive Activity For Older Adults With Mild Cognitive Impairment
Funder
National Health and Medical Research Council
Funding Amount
$490,127.00
Summary
Australia’s population is ageing rapidly and so is the frequency of age-related disorders. Dementia is one of the most frequent mental health disorders of older people and one of the leading causes of years of life lost due to disability in Australia. Mild Cognitive Impairment (MCI) in old age is considered an important clinical state potentially predictive of future cognitive decline. There is increasing evidence that the onset of dementia can be delayed with targeting potentially modifiable ri ....Australia’s population is ageing rapidly and so is the frequency of age-related disorders. Dementia is one of the most frequent mental health disorders of older people and one of the leading causes of years of life lost due to disability in Australia. Mild Cognitive Impairment (MCI) in old age is considered an important clinical state potentially predictive of future cognitive decline. There is increasing evidence that the onset of dementia can be delayed with targeting potentially modifiable risk factors. In older adults, frequent participation in mentally stimulating leisure activities has been associated with stronger cognitive (abilities such as memory) performances and reduced risk of dementia. Further, the rate of cognitive and functional decline can be influenced by cognitive intervention strategies, though few randomised control studies have explored these findings with individuals who have a diagnosis of MCI. The primary focus of this research is to determine whether a structured program of cognitive activity (CA) can delay progression of cognitive decline amongst older adults with MCI. 160 older adults will be randomised (by chance, like the flip of a coin) to either a 10 week CA intervention with a focus on cognitive training and rehabilitation techniques or a 10 week control educational intervention providing information on aging and retirement. Their cognitive performance, quality of life and functional level will be monitored during follow-up. The proposed study will improve the understanding of possible modifying factors of cognition and highlight the potential of intervention in an older age population. The obtained results will have implications for policy recommendations regarding health care resources and facilitate changes in the approach and management of individuals with MCI.Read moreRead less
An Investigation Of The Effects Of Higher Plasma Glucose In The Normal Range On Cerebral Health.
Funder
National Health and Medical Research Council
Funding Amount
$727,524.00
Summary
Until recently it has been assumed that variation in blood sugar levels within the normal range in non-diabetics is innocuous. Recent findings from our team suggest that high normal sugar levels present risks to brain and cognitive health. This project will investigate in detail the extent to which higher sugar levels in healthy individuals living in the community are associated with brain changes over time, and whether these changes are associated with cognitive decline in middle- and old-age.
The Role Of Metals In Healthy Brain Aging: Identification Of Novel Compounds To Prevent Age-related Cognitive Decline
Funder
National Health and Medical Research Council
Funding Amount
$789,733.00
Summary
This grant will explore the basic mechanisms that underlie normal learning and memory. Specifically, we are focussing on how the modulation of metal levels may occur with age, and how this may cause or at least contribute to age-related cognitive impairment. We are also examining a novel therapeutic compound for the treatment of cognitive dysfunction. This work will have implications for both normal and pathological ageing.
Regulating Microglia To Combat Hippocampal-dependent Cognitive Decline In Ageing
Funder
National Health and Medical Research Council
Funding Amount
$493,768.00
Summary
Age-related cognitive decline, a hallmark of dementia, coincides with reduced activity of neural precursor cells and reduced rate of neuron production in the hippocampus – a key brain structure for learning and memory. Importantly, we have demonstrated that exercise can activate neural precursor cells and boost the production of new neurons as well as improve learning and memory. This project will explore the cellular and molecular mechanisms behind these exercise-induced benefits on cognition.
Targeting Central Inflammation To Combat Obesity And Obesity-related Cognitive Dysfunction
Funder
National Health and Medical Research Council
Funding Amount
$470,144.00
Summary
The current obesity epidemic means many of us will suffer from overweight or obesity for at least some of our lives. My findings show obesity can cause inflammation throughout the brain including in regions related to learning and memory. Here I hypothesize that obesity induces long-term changes in the brain’s immune cells, that this can explain why we see susceptibility to cognitive decline in obese individuals, and that we can reverse these negative effects by targeting these immune cells.
The Role Of Metabolic And Inflammatory Factors In Cognitive Decline And Cerebrovascular Pathology In The Elderly
Funder
National Health and Medical Research Council
Funding Amount
$945,987.00
Summary
Metabolic factors and measures of inflammation in the body have recently been shown to influence mental function and increase the risk of developing age-related disorders such as Alzheimer’s disease. The influence metabolic factors and inflammation have on function of the ageing brain is likely to be determined by complex interplay between many factors, such as physical health, lifestyle, nutrition and our genes. By studying these factors and how they relate to one another in large groups of eld ....Metabolic factors and measures of inflammation in the body have recently been shown to influence mental function and increase the risk of developing age-related disorders such as Alzheimer’s disease. The influence metabolic factors and inflammation have on function of the ageing brain is likely to be determined by complex interplay between many factors, such as physical health, lifestyle, nutrition and our genes. By studying these factors and how they relate to one another in large groups of elderly individuals, we will be able to determine the role these factors play in brain ageing. In addition we will be able to determine an ‘at risk’ profile for elderly individuals for accelerated ageing effects. Identification of this profile is important as it will allow the development of interventions which may prevent or delay the onset of cognitive decline in late life. We plan to study the impact of metabolic and inflammatory factors on brain ageing and in two groups of elderly individuals both of which are currently being studied in detail by our research team. By using these existing groups we will minimize the costs associated with our research, but maximize the research benefit and the benefit to society. Our groups include a large community sample of elderly individuals aged 70-90 years and a large group of elderly twins aged over 65 years. Our use of twins for the study is particularly important as it will help us separate genetic and environmental influences on the measures. We will measure multiple metabolic and inflammatory factors in the body and determine their relationship to detailed tests of cognitive function and to cerebrovascular pathology on brain magnetic resonance imaging. We will look at how these factors relate to one another and which factors are most strongly associated with accelerated ageing. We will be able to follow subjects in each group over a 2 year interval to see which factors most strongly predict change in cognitive function and cerebrovascular pathology over time. Our research is unique in its inclusion of multiple factors which may affect brain ageing, its ability to look in detail at the contribution of genetic influences on metabolic and inflammatory factors, and in our planned follow-up of these individuals.Read moreRead less
A European DNA Bank For Deciphering The Missing Heritability Of Alzheimer's Disease (EADB)
Funder
National Health and Medical Research Council
Funding Amount
$1,556,995.00
Summary
Understanding the genetics of Alzheimer’s disease (AD) is one of the best ways of improving our knowledge of the underlying mechanisms of disease development. There is evidence that genetic factors account for up to 80% of the risk for AD. Recent advances in genetics still explain <50% of this risk. This proposal will help two major Australian studies to partner with a large European consortium in trying to understand the “missing” heritability, using existing and novel genetic data.